N-(cyclohexen-1-yl)-N-ethyl-2-(4-hydroxy-4-methylazepan-1-yl)acetamide

C17H30N2O2 — CID 107408318

IUPACN-(cyclohexen-1-yl)-N-ethyl-2-(4-hydroxy-4-methylazepan-1-yl)acetamide
SMILESCCN(C(=O)CN1CCCC(C)(O)CC1)C1=CCCCC1
InChIInChI=1S/C17H30N2O2/c1-3-19(15-8-5-4-6-9-15)16(20)14-18-12-7-10-17(2,21)11-13-18/h8,21H,3-7,9-14H2,1-2H3
InChIKeyUPWDEHSPWOCGOS-UHFFFAOYSA-N
MW294.44 g/mol
LogP2.53
Rot. Bonds4

About N-(cyclohexen-1-yl)-N-ethyl-2-(4-hydroxy-4-methylazepan-1-yl)acetamide

N-(cyclohexen-1-yl)-N-ethyl-2-(4-hydroxy-4-methylazepan-1-yl)acetamide (PubChem CID 107408318) has the molecular formula C17H30N2O2 and a molecular weight of 294.44 g/mol. Its IUPAC name is N-(cyclohexen-1-yl)-N-ethyl-2-(4-hydroxy-4-methylazepan-1-yl)acetamide.

Molecular Properties

Compound NameN-(cyclohexen-1-yl)-N-ethyl-2-(4-hydroxy-4-methylazepan-1-yl)acetamide
PubChem CID107408318
Molecular FormulaC17H30N2O2
Molecular Weight294.44 g/mol
Exact Mass294.23
IUPAC NameN-(cyclohexen-1-yl)-N-ethyl-2-(4-hydroxy-4-methylazepan-1-yl)acetamide
SMILESCCN(C(=O)CN1CCCC(C)(O)CC1)C1=CCCCC1
InChIInChI=1S/C17H30N2O2/c1-3-19(15-8-5-4-6-9-15)16(20)14-18-12-7-10-17(2,21)11-13-18/h8,21H,3-7,9-14H2,1-2H3
InChIKeyUPWDEHSPWOCGOS-UHFFFAOYSA-N
XLogP2.53
TPSA43.78 Ų
H-Bond Donors1
H-Bond Acceptors3
Rotatable Bonds4
Heavy Atoms21
Complexity—

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500294.44
LogP ≤ 52.53
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 103

Analyze N-(cyclohexen-1-yl)-N-ethyl-2-(4-hydroxy-4-methylazepan-1-yl)acetamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

N-(cyclopenten-1-yl)-N-ethyl-2-(4-hydroxy-4-methylazepan-1-yl)acetamide
CID 107407836
N-(cyclohexen-1-yl)-N-ethyl-2-(4-hydroxy-4-methylpiperidin-1-yl)acetamide
CID 80703389
3-amino-1-[2-[cyclohexen-1-yl(ethyl)amino]-2-oxoethyl]pyrrolidine-3-carboxylic acid
CID 107324787
N-(cyclohexen-1-yl)-N-ethyl-2-[4-(2-oxo-2-piperidin-1-ylethyl)piperazin-1-yl]acetamide
CID 55462455
N-(cyclohexen-1-yl)-N-ethyl-2-[4-(hydroxymethyl)piperidin-1-yl]acetamide
CID 60969833
2-[(3S)-3-aminopyrrolidin-1-yl]-N-(cyclohexen-1-yl)-N-ethylacetamide
CID 115302497
N-(cyclohexen-1-yl)-N-ethyl-2-[(3R)-3-methylpiperazin-1-yl]acetamide
CID 104975890
N-(cyclohexen-1-yl)-2-(3,9-diazabicyclo[4.2.1]nonan-3-yl)-N-ethylacetamide
CID 115314324
2-(3-aminoazetidin-1-yl)-N-(cyclopenten-1-yl)-N-ethylacetamide
CID 79005108
2-(3-amino-5-methylpiperidin-1-yl)-N-(cyclohexen-1-yl)-N-ethylacetamide
CID 79994225
N-[1-[2-[cyclohexen-1-yl(ethyl)amino]-2-oxoethyl]piperidin-4-yl]thiophene-2-carboxamide
CID 47548219
N-(cyclopenten-1-yl)-N-ethyl-2-[3-(methylaminomethyl)piperidin-1-yl]acetamide
CID 78967888

Frequently Asked Questions

What is the IUPAC name of N-(cyclohexen-1-yl)-N-ethyl-2-(4-hydroxy-4-methylazepan-1-yl)acetamide?
The IUPAC name of N-(cyclohexen-1-yl)-N-ethyl-2-(4-hydroxy-4-methylazepan-1-yl)acetamide (CID 107408318) is N-(cyclohexen-1-yl)-N-ethyl-2-(4-hydroxy-4-methylazepan-1-yl)acetamide.
What is the SMILES notation for N-(cyclohexen-1-yl)-N-ethyl-2-(4-hydroxy-4-methylazepan-1-yl)acetamide?
The canonical SMILES for N-(cyclohexen-1-yl)-N-ethyl-2-(4-hydroxy-4-methylazepan-1-yl)acetamide is CCN(C(=O)CN1CCCC(C)(O)CC1)C1=CCCCC1.
What is the InChIKey of N-(cyclohexen-1-yl)-N-ethyl-2-(4-hydroxy-4-methylazepan-1-yl)acetamide?
The InChIKey is UPWDEHSPWOCGOS-UHFFFAOYSA-N. The full InChI is InChI=1S/C17H30N2O2/c1-3-19(15-8-5-4-6-9-15)16(20)14-18-12-7-10-17(2,21)11-13-18/h8,21H,3-7,9-14H2,1-2H3.
What are the key properties of N-(cyclohexen-1-yl)-N-ethyl-2-(4-hydroxy-4-methylazepan-1-yl)acetamide?
N-(cyclohexen-1-yl)-N-ethyl-2-(4-hydroxy-4-methylazepan-1-yl)acetamide has a molecular weight of 294.44 g/mol, XLogP of 2.53, 4 rotatable bonds, 1 hydrogen bond donors, and 3 hydrogen bond acceptors.
Where does this data come from?
All data for N-(cyclohexen-1-yl)-N-ethyl-2-(4-hydroxy-4-methylazepan-1-yl)acetamide is sourced from PubChem (CID 107408318), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).